Duration of Antibiotic Therapy
For most common bacterial infections, shorter antibiotic courses (3-7 days) are as effective as traditional longer courses (10-14 days) and should be the standard of care to minimize resistance and adverse events.
Community-Acquired Pneumonia (CAP)
Use a personalized approach based on clinical stability rather than fixed durations 1:
- 3 days of antibiotics for non-severe or moderate CAP if clinically stable at day 3 1
- 5 days if stability is achieved by day 5 1, 2
- 7 days for other uncomplicated forms of CAP 1, 2
- Prolonged duration only indicated when complications occur 1
The 2025 guidelines represent a significant shift toward shorter durations, with recent trials validating 3-day treatment with amoxicillin or injectable beta-lactams for stabilized patients 1. Multiple meta-analyses confirm non-inferiority of short (3-7 days) versus long (>7 days) treatments 1, 2.
Urinary Tract Infections
Complicated UTI and Pyelonephritis
5-7 days of fluoroquinolones or 14 days of trimethoprim-sulfamethoxazole based on susceptibility 3:
- Eight RCTs with >1,300 patients confirm 5-7 days produces similar clinical success as 10-14 days, even with bacteremia 4
- One adequately powered study in men showed 7-day fluoroquinolone or TMP-SMZ courses were non-inferior to 14-day courses despite high rates of anatomic abnormalities 4
Cellulitis
5-6 days of antibiotics active against streptococci for nonpurulent cellulitis in patients able to self-monitor with close primary care follow-up 3.
Intra-Abdominal Infections
4 days of antibiotics after adequate source control 4:
- An RCT of 518 patients showed no difference in surgical site infection, recurrent infection, or death between 4 days versus mean 8 days of treatment 4
- For severe postoperative IAI requiring ICU admission, 8 days was non-inferior to 15 days 4
- Continue only if difficulty achieving source control 4
Skin and Soft Tissue Infections
Shorter durations are increasingly supported across SSTI types 5:
- No benefit to longer durations in obese patients; longer therapy associated with increased treatment failure 5
- For diabetic foot osteomyelitis treated non-surgically: 6 weeks maximum 5
- For diabetic foot osteomyelitis with surgical debridement: 3 weeks produces similar outcomes to 6 weeks 5
- For necrotizing soft tissue infections after source control: 48 hours appears sufficient 5
Gram-Negative Bacteremia
7 days of appropriate antibiotics for patients who are hemodynamically stable, afebrile for 48 hours, with controlled source (UTI, IAI, respiratory, central line, SSTI) 4.
Critical Implementation Points
Common pitfalls to avoid:
- Defaulting to 10-day courses regardless of condition—this remains widespread despite evidence 3
- Prescribing longer durations to prevent resistance—no evidence supports this, and prolonged use actually increases resistance through selection pressure 3
- Continuing antibiotics until all symptoms resolve—clinical stability criteria should guide discontinuation 1, 2
- Extending treatment for carbapenem-resistant organisms without evidence—resistance pattern alone doesn't justify longer duration 6
The evidence consistently demonstrates that shorter courses reduce antibiotic exposure, decrease adverse events (including C. difficile infections occurring in up to 20% of patients), and combat the national threat of antimicrobial resistance without compromising clinical outcomes 3.